SANUWAVE Reports Record Q1 Revenue, Sharp Loss Improvement, Sets Full-Year Outlook

The update points to growth from rising Ultramist supply use with a larger device base.

Overview

SanUWAVE reported $9.6 million in first-quarter revenue, up 3% year over year, as use of single-use Ultramist supplies rose 22%.
The active device base grew to 1,382 systems from 1,292 at year-end, which increased the pool of sites that buy those supplies regularly.
The company posted a $1.1 million operating loss, and it cut net loss to $1.4 million from $6.1 million despite higher R&D and commercial spend.
Management guided to 10–15% year-over-year growth in Q2 and set a 2026 revenue goal of $51 million to $55 million.
Leaders said they are driving wider Ultramist adoption and deeper ties with large health systems while working through new CMS skin-substitute pricing and rural access hurdles.